Naoki Furuya

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 29

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Ejection Fraction

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Thoracic cancer

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, Saori Takata, Kazuyoshi Kuwano, Yuki Misumi, Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, Yumiko Kobayashi, Yuichi Takiguchi, Hiroaki Okamoto
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study). Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi, Tetsuro Kondo, Shuji Murakami, Yoshimasa Shiraishi, Hisao Imai, Daijiro Harada, Kazutoshi Isobe, Hidetoshi Itani, Saori Takata, Kazuyoshi Kuwano, Yuki Misumi, Satoshi Ikeda, Tetsuhiko Asao, Naoki Furuya, Shinobu Hosokawa, Yumiko Kobayashi, Yuichi Takiguchi, Hiroaki Okamoto
Phase II study of durvalumab immediately after completion of chemoradiotherapy in unresectable stage III non-small-cell lung cancer: TORG1937 (DATE study). Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Ishmael A Jaiyesimi, Natasha B Leighl, Nofisat Ismaila, Krishna C Alluri, Narjust Florez, Shirish M Gadgeel, Gregory A Masters, Erin L Schenk, Bryan J Schneider, Lecia V Sequist, Navneet Singh, Lyudmila Bazhenova, Elizabeth Blanchard, Janet Freeman-Daily, Naoki Furuya, Balazs Halmos, Ibrahim Hanna Azar, Sara Kuruvilla, Michael Mullane, Jarushka Naidoo, Joshua E Reuss, David R Spigel, Dwight H Owen, Jyoti D Patel
Therapy for Stage IV Non-Small Cell Lung Cancer With Driver Alterations: ASCO Living Guideline, Version 2023.3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (11) (2024)
Hiroaki Akamatsu, Shunsuke Teraoka, Shinkichi Takamori, Satoru Miura, Hidetoshi Hayashi, Akito Hata, Yukihiro Toi, Yoshimasa Shiraishi, Nobuaki Mamesaya, Yuki Sato, Naoki Furuya, Jun Oyanagi, Yasuhiro Koh, Toshihiro Misumi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Nivolumab Retreatment in Non-Small Cell Lung Cancer Patients Who Responded to Prior Immune Checkpoint Inhibitors and Had ICI-Free Intervals (WJOG9616L). Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi, Toshihiro Misumi, Yukiko Nakamura, Yosuke Kawashima, Naoki Furuya, Yoshimasa Shiraishi, Toshiyuki Harada, Hisashi Tanaka, Satoru Miura, Ayumi Uchiyama, Hideyuki Niwa, Takaaki Tokito, Katsuhiko Naoki, Akihiro Bessho, Yasuhiro Goto, Masahiro Seike, Hiroaki Okamoto
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (20) (2022)
Hiroaki Akamatsu, Shunsuke Teraoka, Shinkichi Takamori, Satoru Miura, Hidetoshi Hayashi, Akito Hata, Yukihiro Toi, Yoshimasa Shiraishi, Nobuaki Mamesaya, Yuki Sato, Naoki Furuya, Jun Oyanagi, Yasuhiro Koh, Toshihiro Misumi, Nobuyuki Yamamoto, Kazuhiko Nakagawa
Nivolumab retreatment in non-small cell lung cancer patients who responded to prior immune-checkpoint inhibitors and had ICI-free intervals (WJOG9616L). Clinical cancer research : an official journal of the American Association for Cancer Research (2022)
Satoshi Ikeda, Tateaki Naito, Satoru Miura, Kentaro Ito, Naoki Furuya, Toshihiro Misumi, Takashi Ogura, Terufumi Kato
Pharmacotherapy for Advanced Non-Small Cell Lung Cancer with Performance Status 2 without Druggable Gene Alterations: Could Immune Checkpoint Inhibitors Be a Game Changer? Cancers 14 (19) (2022)
Tadashi Sakaguchi, Kentaro Ito, Naoki Furuya, Kei Morikawa, Kentaro Fujiwara, Yoichi Nishii, Takeo Inoue, Osamu Hataji, Masamichi Mineshita
Assessment of chemotherapy regimens on radiation pneumonitis in patients with unresectable stage III non-small-cell lung cancer after definitive chemoradiotherapy. Thoracic cancer 12 (13) (2021)
Tomoyuki Miyazawa, Kei Morikawa, Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura, Motohiro Chosokabe, Naoki Furuya, Hideki Marushima, Koji Kojima, Masamichi Mineshita, Junki Koike, Hisashi Saji
Solid histological component of adenocarcinoma might play an important role in PD-L1 expression of lung adenocarcinoma. Thoracic cancer (2021)
Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori, Kumiko Hayashi, Shogo Kumagai, Yuji Shibata, Takuma Hayashida, Kana Watanabe, Tatsuro Fukuhara, Takaya Ikeda, Kiyotaka Yoh, Terufumi Kato, Kazumi Nishino, Atsushi Nakamura, Ichiro Nakachi, Shoichi Kuyama, Naoki Furuya, Jun Sakakibara-Konishi, Isamu Okamoto, Kageaki Taima, Noriyuki Ebi, Haruko Daga, Akira Yamasaki, Masahiro Kodani, Hibiki Udagawa, Keisuke Kirita, Yoshitaka Zenke, Kaname Nosaki, Eri Sugiyama, Tetsuya Sakai, Tokiko Nakai, Genichiro Ishii, Seiji Niho, Atsushi Ohtsu, Susumu S Kobayashi, Koichi Goto
The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. Nature 600 (7888) (2021)
Naoki Furuya, Makoto Nishino, Kazushige Wakuda, Satoshi Ikeda, Takashi Sato, Ryota Ushio, Shigeru Tanzawa, Masafumi Sata, Kentaro Ito
Real-world efficacy of atezolizumab in non-small cell lung cancer: A multicenter cohort study focused on performance status and retreatment after failure of anti-PD-1 antibody. Thoracic cancer 12 (5) (2021)
Kanji Otsubo, Hiroki Sakai, Hiroyuki Kimura, Tomoyuki Miyazawa, Hideki Marushima, Koji Kojima, Naoki Furuya, Masamichi Mineshita, Motohiro Chosokabe, Junki Koike, Hisashi Saji
Thoracic mesenchymal malignant tumors and programed cell death ligand-1 status: Clinicopathologic and prognostic analysis of eight pulmonary sarcomatoid carcinomas and eight malignant mesotheliomas. Thoracic cancer 12 (23) (2021)
Naoki Furuya, Koji Kojima, Hideki Marushima, Kazutaka Kakinuma, Akihito Tsunoda, Eriko Koda, Hajime Tsuruoka, Kohei Nishida, Takeo Inoue, Hisashi Saji, Masamichi Mineshita
Successful treatment with nivolumab in a patient with lung adenocarcinoma complicated by pulmonary aspergilloma. Thoracic cancer 11 (11) (2020)
Naoki Furuya, Shingo Matsumoto, Kazutaka Kakinuma, Kei Morikawa, Takeo Inoue, Hisashi Saji, Koichi Goto, Masamichi Mineshita
Suitability of transbronchial brushing cytology specimens for next-generation sequencing in peripheral lung cancer. Cancer science 112 (1) (2020)
Tadashi Sakaguchi, Naoki Furuya, Kentaro Ito, Naoya Hida, Kei Morikawa, Yuko Komase, Takeo Inoue, Osamu Hataji, Masamichi Mineshita
The efficacy and safety of ramucirumab plus docetaxel in older patients with advanced non-small cell lung cancer. Thoracic cancer 11 (6) (2020)
Azusa Tanimoto, Shingo Matsumoto, Shinji Takeuchi, Sachiko Arai, Koji Fukuda, Akihiro Nishiyama, Kiyotaka Yoh, Takaya Ikeda, Naoki Furuya, Kazumi Nishino, Yuichiro Ohe, Koichi Goto, Seiji Yano
Proteasome Inhibition Overcomes ALK-TKI Resistance in ALK-Rearranged/TP53-Mutant NSCLC via Noxa Expression. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (5) (2020)